Humonix Biosciences is a specialty pharma research company that uses an innovative human tissue engineering platform technology to reduce the cost of drug development.
Humonix collaborates with industry and academic partners to help screen for and identify lead candidates, elucidate their MOA and validate their efficacy.
Humonix's 3D tissue technology can reduce the risk of clinical trial failure while saving time, labor and development costs. Early identification and validation of effective compounds or biologics allows our partners to confidently enter clinical trials.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 257 Fuller Rd,
- Industry
- Biotechnology
- Website
- https://www.humonixbio.com/
- Keywords
- Glaucoma, Drug Discovery, 3D Human Tissue, Drug Screening, Diabetic Retinopathy, Macular Edema, Blood Retinal Barrier, Pulmonary Fibrosis, Pulmonary Hypertension.
- HQ
- Albany, NY
Humonix Biosciences, Inc. Questions
Humonix Biosciences, Inc.'s website is https://www.humonixbio.com/
Humonix Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/humonix-biosciences
Humonix Biosciences, Inc. has
7 employees.
View email and phone details for 7
employees at Humonix Biosciences, Inc..
Humonix Biosciences, Inc.'s industry is
Biotechnology
Humonix Biosciences, Inc.'s top competitors are
Qlaris Bio, Inc.,
Chempass Ltd.,
Mitomarin,
Kallyope,
Celmatix Therapeutics,
Yds Pharmatech,
Sigmadrugs - Research,
Orbital Therapeutics,
Vrg Therapeutics,
Apheon Bioscience.
Humonix Biosciences, Inc.'s categories are Biotechnology
Humonix Biosciences, Inc.'s founding year is 2015
